0
0.5
1
1.5
2+
Mortality
47%
Improvement
Relative Risk
c19early.org
Remdesivir for COVID-19 Solh et al. LATE TREATMENT
Is late treatment with remdesivir beneficial for COVID-19?
Retrospective 643 patients in the USA
Lower mortality with remdesivir (p=0.001)
Solh et al., medRxiv, doi:10.1101/2020.10.16.20214130
Favors remdesivir
Favors control